CompanyTrack
N

NUVISION BIOTHERAPIES LIMITED

Active Nottingham

Manufacture of pharmaceutical preparations

21 employees Website
Life sciences and medical technology Manufacture of pharmaceutical preparations
N

NUVISION BIOTHERAPIES LIMITED

Manufacture of pharmaceutical preparations

Founded 7 Apr 2015 Active Nottingham, England 21 employees nu-vision.co.uk
Life sciences and medical technology Manufacture of pharmaceutical preparations
Accounts Submitted 7 Feb 2025
Confirmation Statement Submitted 11 Feb 2025
Net assets £-177.05K £1.12M 2024 year on year
Total assets £393.08K £737.93K 2024 year on year
Total Liabilities £602.63K £418.95K 2024 year on year
Charges 1
1 outstanding

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Medicity, D6 Building Thane Road Nottingham NG90 6BH England

Office ()

Nottingham, Nottingham, United Kingdom, Europe

Credit Report

Discover NUVISION BIOTHERAPIES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£44.29k

Decreased by £601.38k (-93%)

Net Assets

-£177.05k

Decreased by £1.12M (-119%)

Total Liabilities

£602.63k

Increased by £418.95k (+228%)

Turnover

N/A

Employees

21

Increased by 3 (+17%)

Debt Ratio

153%

Increased by 137 (+856%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£138k awarded
Show:

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 63,828 Shares £4.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Mar 20254,154£270k£65
18 Jul 20243,076£200k£65
10 Dec 20237,105£462k£65
3 Jan 202314,558£946k£65
1 Apr 202124,946£1.62m£65

Officers

Officers

7 active 10 resigned
Status
Andrew HillDirectorBritishEngland6320 Jan 2022Active
Andrew HopkinsonDirectorBritishEngland4920 May 2015Active
Jonathan Mark TreherneDirectorBritishEngland6419 Jan 2018Active
Mercia Fund Management (nominees) LimitedCorporate-directorUnited KingdomUnknown26 Nov 2020Active
Noel WatersDirectorIrishEngland6819 Jun 2025Active
Roger Peter TeasdaleDirectorBritishEngland591 Mar 2018Active
Timothy John GrayDirectorBritishEngland6219 Jun 2025Active

Shareholders

Shareholders (65)

Wcs Nominees Limited As Nominee On Behalf Of The Investors In Pioneer Life Sciences Eis Knowledge Intensive Fund
4.8%
6,92211 Feb 2025
Yakup Yilmaz
2.1%
3,07611 Feb 2025
Timothy Gray
0.5%
76911 Feb 2025

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Mercia Growth Nominees 5 Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent

Ugf Nominees Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent

Mercia Growth Nominees 4 Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent

The University Of Nottingham

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

NUVISION BIOTHERAPIES LIMITED Current Company

Charges

Charges

1 outstanding

Documents

Company Filings

DateCategoryDescriptionDocument
24 Jun 2025OfficersAppointment of Mr Timothy John Gray as director on 2025-06-19View(2 pages)
24 Jun 2025OfficersAppointment of Mr Noel Waters as director on 2025-06-19View(2 pages)
15 Apr 2025CapitalAllotment of shares (GBP 217.455) on 2025-03-25View(5 pages)
11 Feb 2025Confirmation StatementConfirmation statement made on 2025-02-11 with updatesView(12 pages)
7 Feb 2025AccountsAnnual accounts made up to 2024-06-30View(10 pages)
24 Jun 2025 Officers

Appointment of Mr Timothy John Gray as director on 2025-06-19

24 Jun 2025 Officers

Appointment of Mr Noel Waters as director on 2025-06-19

15 Apr 2025 Capital

Allotment of shares (GBP 217.455) on 2025-03-25

11 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-02-11 with updates

7 Feb 2025 Accounts

Annual accounts made up to 2024-06-30

Recent Activity

Latest Activity

Appointment of Mr Timothy John Gray as director on 2025-06-19

7 months ago on 24 Jun 2025

Appointment of Mr Noel Waters as director on 2025-06-19

7 months ago on 24 Jun 2025

Allotment of shares (GBP 217.455) on 2025-03-25

10 months ago on 15 Apr 2025

Confirmation statement made on 2025-02-11 with updates

1 years ago on 11 Feb 2025

Annual accounts made up to 2024-06-30

1 years ago on 7 Feb 2025